首页> 外国专利> NUCLEAR PHOSPHOPROTEINS FOR PROGNOSTICATING LYMPHOID OR EPITHELIAL CANCERS

NUCLEAR PHOSPHOPROTEINS FOR PROGNOSTICATING LYMPHOID OR EPITHELIAL CANCERS

机译:核蛋白可预防淋巴癌或上皮癌

摘要

The present invention suggests that phosphoproteins (32KD, 35KD and 42KD) of three mammalian nuclei are useful for the diagnosis and prognosis of tumors derived from lymphoid and epithelial cells. These three proteins are immunologically correlated. The expression levels of these proteins correlate with the malignant potential of lymphoid and epithelial tumors. In some cases, the distribution of cell levels of these proteins is indicative of malignant potential. Antibodies reactive with these proteins are presented as diagnostic vessels, and nucleic acid probes and primers for quantifying messenger RNAs encoding the proteins are presented. A method of making and purifying these proteins is also shown.
机译:本发明表明,三个哺乳动物核的磷蛋白(32KD,35KD和42KD)可用于诊断和预后来自淋巴样和上皮细胞的肿瘤。这三种蛋白质是免疫相关的。这些蛋白质的表达水平与淋巴样和上皮肿瘤的恶性潜能相关。在某些情况下,这些蛋白的细胞水平分布表明存在恶性潜能。与这些蛋白质发生反应的抗体作为诊断容器,并提供了用于定量编码该蛋白质的信使RNA的核酸探针和引物。还显示了制备和纯化这些蛋白质的方法。

著录项

  • 公开/公告号KR1002332080000B1

    专利类型

  • 公开/公告日1999-12-01

    原文格式PDF

  • 申请/专利权人 THE JOHNS HOPKINS UNIVERSITY;

    申请/专利号KR1019930700289

  • 发明设计人 파스테르나크 게리 알;

    申请日1993-02-01

  • 分类号C07K15/00;

  • 国家 KR

  • 入库时间 2022-08-22 01:46:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号